Total Payments
$582.31
2020 Payments
$32.15
Companies
8
Transactions
33
Medicare Patients
844
Medicare Billing
$109,341
Payment Breakdown by Category
Food & Beverage$582.31 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $582.31 | 33 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $255.66 | 14 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $126.65 | 7 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $75.89 | 4 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $67.51 | 4 | $0 (2017) |
| Lundbeck LLC | $19.53 | 1 | $0 (2017) |
| Neos Therapeutics, LP | $13.16 | 1 | $0 (2017) |
| Tris Pharma Inc | $12.09 | 1 | $0 (2017) |
| Vanda Pharmaceuticals Inc. | $11.82 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $32.15 | 2 | Alkermes, Inc. ($32.15) |
| 2019 | $159.65 | 9 | Alkermes, Inc. ($126.83) |
| 2017 | $390.51 | 22 | Alkermes, Inc. ($96.68) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/12/2020 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: CNS | ||||||
| 01/29/2020 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: CNS | ||||||
| 12/19/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: CNS | ||||||
| 11/14/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: CNS | ||||||
| 10/29/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: CNS | ||||||
| 10/11/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: CNS | ||||||
| 09/05/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: CNS | ||||||
| 08/19/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Neuroscience | ||||||
| 06/20/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: CNS | ||||||
| 06/12/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Neuroscience | ||||||
| 05/01/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: CNS | ||||||
| 11/02/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: CNS | ||||||
| 10/24/2017 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Neuroscience | ||||||
| 10/12/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: CNS | ||||||
| 09/14/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: CNS | ||||||
| 09/07/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: CNS | ||||||
| 07/20/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: CNS | ||||||
| 06/28/2017 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: ADHD | ||||||
| 05/26/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: CNS | ||||||
| 05/24/2017 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.53 | General |
| Category: PSYCHIATRY | ||||||
| 05/17/2017 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Neuroscience | ||||||
| 05/11/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: CNS | ||||||
| 05/10/2017 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: PSYCHIATRY | ||||||
| 05/04/2017 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Neuroscience | ||||||
| 04/27/2017 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 130 | 188 | $81,533 | $18,065 |
| 2022 | 5 | 175 | 240 | $97,103 | $21,651 |
| 2021 | 5 | 190 | 287 | $109,446 | $27,871 |
| 2020 | 8 | 349 | 513 | $171,331 | $41,754 |
Total Patients
844
Total Services
1,228
Medicare Billing
$109,341
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 87 | 105 | $61,259 | $12,532 | 20.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 70 | $15,645 | $4,307 | 27.5% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 11 | 13 | $4,629 | $1,226 | 26.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 109 | 122 | $72,224 | $15,427 | 21.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 29 | 55 | $11,550 | $2,918 | 25.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 21 | $6,342 | $1,663 | 26.2% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 11 | 19 | $4,066 | $876.22 | 21.5% |
| 99282 | Emergency department visit for problem of mild to moderate severity | Facility | 2022 | 13 | 23 | $2,921 | $766.91 | 26.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 115 | 140 | $73,880 | $18,424 | 24.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 15 | 50 | $15,219 | $3,975 | 26.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 34 | 60 | $12,769 | $3,399 | 26.6% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 13 | 24 | $4,836 | $1,337 | 27.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 13 | 13 | $2,742 | $737.23 | 26.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 161 | 200 | $93,498 | $21,980 | 23.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 71 | 150 | $32,062 | $8,371 | 26.1% |
| 90791 | Psychiatric diagnostic evaluation | Facility | 2020 | 36 | 37 | $15,649 | $3,606 | 23.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 18 | 36 | $11,100 | $2,997 | 27.0% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 23 | 41 | $7,764 | $2,094 | 27.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 16 | 16 | $7,108 | $1,655 | 23.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 13 | 20 | $2,345 | $596.49 | 25.4% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2020 | 11 | 13 | $1,805 | $452.72 | 25.1% |
About Dr. Hasan Baloch, M.D
Dr. Hasan Baloch, M.D is a Mental Health healthcare provider based in Smithfield, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457432023.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hasan Baloch, M.D has received a total of $582.31 in payments from pharmaceutical and medical device companies, with $32.15 received in 2020. These payments were reported across 33 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($582.31).
As a Medicare-enrolled provider, Baloch has provided services to 844 Medicare beneficiaries, totaling 1,228 services with total Medicare billing of $109,341. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Mental Health
- Other Specialties Child & Adolescent Psychiatry, Psychiatry
- Location Smithfield, NC
- Active Since 10/18/2006
- Last Updated 05/06/2021
- Taxonomy Code 101YM0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1457432023
Products in Payments
- ARISTADA (Drug) $158.98
- Aristada 441 mg (Drug) $96.68
- LATUDA (Drug) $75.89
- INVEGA SUSTENNA (Drug) $64.24
- ABILIFY MAINTENA (Drug) $51.28
- SPRAVATO (Drug) $32.82
- INVEGA TRINZA (Drug) $29.59
- REXULTI (Drug) $19.53
- Adzenys XR-ODT (Drug) $13.16
- Dyanavel XR (Drug) $12.09
- Fanapt (Drug) $11.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Mental Health Doctors in Smithfield
Mr. Jim Tedrow, Lpc, LPC
Mental Health
Mental Health
Laura Butler, Ma, Lcmhc, MA, LCMHC
Mental Health
Mental Health
Kate Bowen Young, Lmhc, LMHC
Mental Health
Mental Health
Ms. Marilyn Lundin, Msw, Lcsw, MSW, LCSW
Mental Health
Mental Health
Keith Berube, Cags Lmhc, CAGS LMHC
Mental Health
Mental Health
Lydia Torres, Lcmhc, LCMHC
Mental Health
Mental Health